These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 32375405)

  • 21. The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor.
    Liu Y; Colby JK; Zuo X; Jaoude J; Wei D; Shureiqi I
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
    Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
    Knapp P; Jarzabek K; Błachnio A; Zbroch T
    Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) protects against ceramide-induced cellular toxicity in rat brain astrocytes and neurons by activation of ceramide kinase.
    Aleshin S; Reiser G
    Mol Cell Neurosci; 2014 Mar; 59():127-34. PubMed ID: 24513118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of PPAR activity via phosphorylation.
    Burns KA; Vanden Heuvel JP
    Biochim Biophys Acta; 2007 Aug; 1771(8):952-60. PubMed ID: 17560826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARs and Angiogenesis-Implications in Pathology.
    Wagner N; Wagner KD
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing the Role of PPARβ/δ in Carcinogenesis.
    Peters JM; Gonzalez FJ; Müller R
    Trends Endocrinol Metab; 2015 Nov; 26(11):595-607. PubMed ID: 26490384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
    Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PPAR family and its relationship to metabolic syndrome].
    Zhang XY; Chen LH; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):6-12. PubMed ID: 15881336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.
    Tenenbaum A; Motro M; Fisman EZ
    Cardiovasc Diabetol; 2005 Sep; 4():14. PubMed ID: 16168052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation.
    Wagner KD; Benchetrit M; Bianchini L; Michiels JF; Wagner N
    J Pathol; 2011 Aug; 224(4):575-88. PubMed ID: 21598253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of cytosolic phospholipase A2 alpha signalling pathway in spontaneous and transforming growth factor-beta-induced activation of rat hepatic stellate cells.
    Zhao L; Gandhi CR; Gao ZH
    Liver Int; 2011 Nov; 31(10):1565-73. PubMed ID: 22093332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Δ
    Hirao-Suzuki M; Takeda S; Watanabe K; Takiguchi M; Aramaki H
    Arch Biochem Biophys; 2019 Feb; 662():219-225. PubMed ID: 30553767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
    Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
    Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
    Takada I; Makishima M
    Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.
    Gaspar JC; Okine BN; Llorente-Berzal A; Roche M; Finn DP
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32102354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain.
    Aleshin S; Reiser G
    Biol Chem; 2013 Dec; 394(12):1553-70. PubMed ID: 24021597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home.
    Billin AN
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1465-71. PubMed ID: 18808307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.